Brief: Oncopeptides Q3 Operating Profit SEK -47.053 Million
05/11/2025 07:00
Nov 05 (Reuters) - Oncopeptides Q3 net income SEK -60.894 million. Q3 adjusted EPS SEK -0.27 Q3 sales SEK 20.214 million Q3 adjusted free cash flow SEK -33.701 million
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy